Technology ❯ Artificial Intelligence ❯ Machine Learning

Drug Discovery

Biotechnology Pharmaceutical Research Generative AI AI-Designed Drugs Computational Biology Predictive Modeling Biomedical Applications Biotech Platforms Genomics Clinical Trials

3 ARTICLES

last mo.

AI Pipeline Finds Two Novel Antibiotic Leads Against Drug‑Resistant Gonorrhea

A graph neural network that screened millions of virtual compounds produced two preclinical hits, offering a faster route to new drug candidates while those leads still require optimization and human testing.

4 ARTICLES

2mo ago

AbbVie Extends Rinvoq U.S. Exclusivity to 2037 as AI Biotechs Move From Models to Medicines

13 ARTICLES

this yr.

AI-Designed Antibiotics Show Preclinical Promise, Face Translational Hurdles

5 ARTICLES

last yr.

Isomorphic Labs Nears First Human Trials of AI-Designed Drugs

5 ARTICLES

last yr.

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

5 ARTICLES

last yr.

Isomorphic Labs Secures $600M to Advance AI-Driven Drug Discovery

4 ARTICLES

last yr.

Google DeepMind Spinoff Plans AI-Designed Drug Trials by Year-End

Drug Discovery

AI Pipeline Finds Two Novel Antibiotic Leads Against Drug‑Resistant Gonorrhea

SandboxAQ Integrates Physics-Grounded Drug Discovery Models Into Claude

OpenAI Launches GPT-Rosalind, a Biology-Tuned AI for Drug Discovery

AWS Launches Amazon Bio Discovery to Speed Early Drug Discovery

Nvidia, Eli Lilly Commit Up to $1 Billion for Bay Area AI Drug Discovery Lab

Insilico and Servier Strike Up to $888 Million AI-Oncology Partnership

Insilico Medicine Surges on Hong Kong Debut After HK$2.3 Billion IPO

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

AbbVie Extends Rinvoq U.S. Exclusivity to 2037 as AI Biotechs Move From Models to Medicines

AI-Designed Antibiotics Show Preclinical Promise, Face Translational Hurdles

Isomorphic Labs Nears First Human Trials of AI-Designed Drugs

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

Isomorphic Labs Secures $600M to Advance AI-Driven Drug Discovery

Google DeepMind Spinoff Plans AI-Designed Drug Trials by Year-End